background
acut
viral
bronchiol
lead
caus
hospit
among
infant
first
year
life
infant
hospit
bronchiol
present
risk
factor
otherwis
healthi
object
determin
genet
featur
associ
risk
sever
cours
bronchiol
method
prospect
evalu
infant
sever
bronchiol
admit
three
hospit
period
requir
oxygen
therapi
control
group
consist
healthi
adult
patient
evalu
presenc
comorbid
prematur
birth
chronic
respiratori
diseas
congenit
heart
diseas
underw
nasopharyng
aspir
test
viru
detect
multiplexpcr
snp
identif
immun
respons
gene
patient
outcom
assess
result
observ
associ
snp
bronchiol
caus
respiratori
syncyti
viru
rsv
rsvsubtypea
bronchiol
caus
rhinoviru
snp
vdr
associ
progress
death
snp
associ
length
oxygen
use
snp
associ
requir
intens
care
unit
admiss
snp
associ
need
mechan
ventil
conclus
find
provid
evid
snp
associ
presenc
bronchiol
snp
vdr
associ
sever
bronchiol
acut
viral
bronchiol
lead
caus
hospit
among
infant
age
month
approxim
bronchiol
admiss
occur
annual
unit
state
estim
cost
billion
meissner
ralston
et
al
hall
et
al
respiratori
syncyti
viru
rsv
caus
agent
approxim
bronchiol
case
nearli
children
becom
infect
viru
first
two
year
life
meissner
ralston
et
al
hall
et
al
rsv
infect
rang
mild
upper
respiratori
ill
sever
bronchiol
may
requir
admiss
intens
care
unit
icu
mechan
ventil
possibl
lead
death
treatment
support
meissner
ralston
et
al
nation
collabor
centr
women
children
health
uk
global
rsv
estim
caus
death
per
year
among
children
younger
five
year
age
meissner
second
frequent
viru
bronchiol
rhinoviru
implic
approxim
case
occur
case
meissner
ralston
et
al
bronchiol
progress
mild
sever
diseas
import
recogn
risk
factor
predispos
sever
diseas
recent
publish
review
topic
includ
prematur
passiv
smoke
young
age
absenc
breastfeed
chronic
lung
diseas
congenit
heart
diseas
risk
factor
controversi
literatur
alvarez
et
al
controversi
also
exist
regard
influenc
type
viru
presenc
codetect
sever
bronchiol
et
al
weigl
et
al
da
silva
et
al
brand
et
al
infant
hospit
bronchiol
present
risk
factor
otherwis
healthi
led
research
believ
epidemiolog
factor
sole
respons
determin
preval
sever
bronchiol
might
influenc
genet
variabl
inde
one
studi
includ
pair
twin
fraction
hospit
rsv
bronchiol
found
correl
homozyg
twin
dizygot
twin
estim
genet
contribut
rsv
sever
thomsen
et
al
bronchiol
infect
restrict
superfici
cell
respiratori
epithelium
epitheli
cell
recogn
rsv
special
pattern
recognit
receptor
known
toll
receptor
tool
like
receptor
tlr
human
tolllik
famili
protein
consist
least
member
pattern
recognit
receptor
present
macrophag
dendrit
cell
repres
critic
link
immun
stimul
produc
microorgan
initi
host
defens
tal
et
al
et
al
goutaki
et
al
murawski
et
al
mailaparambil
et
al
tolllik
receptor
tlr
princip
express
macrophag
dendrit
cell
cell
type
serv
transmembran
signal
receptor
lipopolysaccharid
lp
gramneg
bacteria
also
involv
acut
innat
immun
respons
rsv
previou
studi
shown
evid
engag
pattern
recognit
rsv
f
glycoprotein
express
activ
rsv
bronchiol
genet
variat
repres
risk
factor
rsv
infect
tal
et
al
et
al
goutaki
et
al
also
carri
polymorph
associ
bronchiol
murawski
et
al
mailaparambil
et
al
well
gene
cc
motif
chemokin
ligand
also
known
regul
activ
normal
cell
express
secret
rant
amanatid
et
al
vitamin
receptor
vdr
kresfeld
et
al
janssen
et
al
induc
nitric
oxid
synthas
interferon
alpha
jun
protooncogen
transcript
factor
subunit
jun
janssen
et
al
aim
studi
determin
genet
featur
associ
sever
cours
risk
bronchiol
prospect
evalu
sever
acut
viral
bronchiol
patient
age
year
admit
three
hospit
region
citi
campina
paulo
state
brazil
period
jan
requir
oxygen
therapi
patient
group
case
one
hundr
thirtyon
patient
comorbid
prematur
birth
chronic
respiratori
diseas
congenit
heart
diseas
diagnosi
bronchiol
base
clinic
data
use
wide
accept
definit
consid
first
episod
acut
respiratori
distress
wheez
preced
upper
airway
symptom
rhinorrhea
cough
without
fever
children
year
age
ralston
et
al
sever
bronchiol
criterion
oxygen
satur
patient
condit
admit
oxygen
therapi
ralston
et
al
patient
previou
wheez
exclud
patient
admit
icu
oxygen
satur
remain
even
patient
get
inspir
oxygen
fraction
patient
submit
mechan
ventil
arteri
partial
pressur
oxygen
mm
hg
arteri
partial
pressur
carbon
dioxid
mm
hg
arteri
blood
ga
analysi
oxygen
therapi
suspend
oxygen
satur
remain
room
air
patient
discharg
h
suspend
oxygen
therapi
patient
evalu
presenc
comorbid
prematur
birth
chronic
respiratori
diseas
congenit
heart
diseas
epidemiolog
variabl
birth
weight
gender
cesarean
deliveri
gestat
age
breastfeed
matern
smoke
pregnanc
passiv
smoke
exposur
allergi
parent
sibl
number
sibl
number
person
hous
mold
exposur
pet
hous
syndrom
day
care
attend
mother
year
educ
parent
guardian
answer
questionnair
epidemiolog
factor
outcom
diseas
studi
perform
longitudin
followup
patient
time
discharg
evalu
length
hospit
stay
length
oxygen
use
need
length
icu
stay
need
length
mechan
ventil
progress
death
patient
underw
nasopharyng
aspir
detect
virus
blood
collect
identif
polymorph
control
group
consist
healthi
control
age
year
randomli
invit
particip
studi
person
famili
histori
lung
chronic
diseas
two
gener
geograph
region
patient
group
particip
control
group
interview
rule
hospit
childhood
respiratori
problem
way
elimin
possibl
present
sever
acut
viral
bronchiol
studi
healthi
control
includ
preexist
cohort
blood
bank
patient
popul
andor
patient
parent
studi
ancestri
perform
due
high
cost
analysi
use
control
group
healthi
adult
use
accept
tool
appli
larg
number
genet
associ
studi
tal
et
al
mailaparambil
et
al
amanatid
et
al
janssen
et
al
arruvito
et
al
ricciardolo
et
al
cell
reagent
qiagen
valencia
ca
usa
ad
nasopharyng
aspir
ratio
store
store
materi
centrifug
supernat
discard
cell
pellet
resuspend
buffer
rlt
plu
dna
rna
isol
perform
use
allprep
dnarna
mini
kit
qiagen
valencia
ca
usa
accord
manufactur
protocol
cdna
synthes
use
high
capac
cdna
revers
transcript
kit
appli
biosystemsthermo
fisher
scientif
paulo
brazil
accord
manufactur
protocol
sampl
test
use
ace
detect
kit
seegen
concord
ca
usa
type
rna
virus
two
type
dna
virus
accord
manufactur
instruct
pcr
conduct
thermocycl
mastercycl
paulo
brazil
base
manufactur
protocol
final
volum
contain
cdna
cdna
dna
concentr
includ
ace
primer
b
c
solut
master
mix
dna
polymeras
buffer
contain
dntp
dye
amplifi
pcr
product
analyz
agaros
gel
stain
gelr
biotium
inc
hayward
ca
chose
studi
frequent
viru
cite
literatur
caus
bronchiol
meissner
ralston
et
al
snp
enrol
data
select
base
previou
publish
studi
tal
et
al
et
al
goutaki
et
al
murawski
et
al
mailaparambil
et
al
amanatid
et
al
kresfeld
et
al
janssen
et
al
arruvito
et
al
puthothu
et
al
lee
et
al
fan
et
al
ricciardolo
et
al
snp
studi
biallel
genom
dna
extract
blood
sampl
use
dna
blood
mini
kit
qiagen
valencia
ca
usa
accord
manufactur
protocol
realtim
pcr
platform
system
thermo
fisher
scientif
paulo
brazil
use
screen
follow
polymorph
genotyp
plate
format
pn
vdr
vdr
jun
epidemiolog
laboratori
data
describ
frequenc
percentag
categor
variabl
mean
standard
deviat
median
minimum
maximum
quantit
variabl
data
diseas
outcom
compar
patient
polymorph
frequenc
compar
patient
control
also
analyz
polymorph
frequenc
patient
type
viru
rsv
specif
rsv
subtyp
rsv
subtyp
b
rhinoviru
viru
codetect
compar
subgroup
control
second
analysi
previous
mention
comparison
perform
exclud
patient
comorbid
prematur
birth
chronic
respiratori
diseas
congenit
heart
diseas
group
remain
patient
analysi
perform
exclud
possibl
influenc
comorbid
patient
outcom
fisher
exact
test
test
appli
compar
categor
data
report
odd
ratio
confid
interv
twosid
p
consid
statist
signific
data
analyz
use
statist
packag
social
scienc
softwar
spss
inc
chicago
il
evalu
minor
allel
frequenc
maf
hardyweinberg
equilibrium
hwe
use
oeg
softwar
rodriguez
et
al
order
evalu
genet
interact
among
polymorph
clinic
data
sampl
use
multifactor
dimension
reduct
mdr
model
nonparametr
genet
environment
modelfre
data
mine
nonlinear
interact
identif
among
genet
environment
attribut
gola
et
al
adjust
result
multipl
comparison
perform
mdr
permut
test
sampl
total
permut
detail
statist
analysi
associ
studi
model
singl
nucleotid
polymorph
snp
evalu
perform
comparison
consid
major
possibl
genet
associ
includ
allel
analysi
exampl
regard
one
hypothet
snp
allel
allel
perform
allel
analysi
genotyp
comparison
versu
versu
ii
versu
iii
versu
iv
versu
chose
present
associ
p
valu
b
model
calcul
presenc
codomin
calcul
three
possibl
p
valu
codomin
model
versu
ii
versu
iii
versu
c
overdomin
analysi
overdomin
analysi
made
consid
import
contribut
heterozyg
genotyp
maintain
preval
sever
diseas
studi
literatur
includ
cancer
asthma
although
mani
studi
report
import
heterozyg
genotyp
preval
differ
diseas
role
heterozygosi
well
known
mani
case
need
better
understood
genet
associ
studi
differ
popul
bonferroni
correct
associ
studi
includ
genet
variabl
environment
variabl
viral
identif
clinic
data
patient
healthi
control
allow
possibl
perform
multipl
comparison
bonferroni
correct
method
employ
minim
effect
multipl
comparison
presenc
fals
posit
test
snp
two
show
amplif
bonferroni
correct
appli
correct
p
valu
carri
multipli
bonferroni
correct
method
multipl
test
publish
even
wide
applic
use
author
consid
unnecessari
carri
correct
decid
present
data
correct
uncorrect
addit
refer
statist
model
appli
studi
set
onlin
supplement
materi
studi
approv
nation
research
ethic
commiss
conduct
accord
declar
helsinki
principl
legal
repres
patient
particip
control
group
receiv
explan
research
gave
written
inform
consent
tabl
show
patient
demograph
clinic
characterist
tabl
show
detail
virus
identifi
one
hundr
eightyon
patient
includ
studi
patient
underw
nasopharyng
aspir
viral
identif
posit
case
frequent
detect
viru
rsv
sampl
follow
rhinoviru
present
sampl
one
hundr
thirtyon
patient
comorbid
patient
underw
nasopharyng
aspir
viral
identif
posit
case
frequent
detect
viru
group
rsv
sampl
follow
rhinoviru
present
sampl
control
group
use
achiev
snp
genotyp
frequenc
associ
sever
acut
viral
bronchiol
group
tabl
show
snp
descript
includ
maf
hwe
snp
vdr
jun
assay
fail
test
snp
hwe
patient
control
subject
moreov
snp
hwe
control
subject
fig
tabl
show
associ
polymorph
presenc
bronchiol
differ
type
viru
evalu
presenc
bronchiol
differ
type
viru
reveal
associ
snp
ct
bronchiol
caus
rsv
ci
rsv
subtyp
ci
specif
snp
gg
bronchiol
caus
rhinoviru
ci
patient
without
comorbid
observ
associ
snp
gg
bronchiol
caus
rhinoviru
ci
fig
tabl
show
associ
polymorph
bronchiol
sever
snp
ag
ci
cc
vdr
ci
associ
progress
death
tt
ci
tc
ci
icu
admiss
cc
ct
ci
tt
ci
need
mechan
ventil
data
express
mean
standard
deviat
median
rang
frequenc
percentag
ae
alvarez
et
al
gene
patient
without
comorbid
snp
associ
progress
death
four
patient
die
studi
heterozyg
snp
p
addit
cc
ci
tt
ci
associ
need
mechan
ventil
gt
ci
length
oxygen
use
tt
ci
icu
admiss
heterozyg
genotyp
present
patient
requir
icu
admiss
p
bonferroni
correct
follow
associ
maintain
p
cc
tt
patient
rhinoviru
infect
fig
tabl
tt
icu
admiss
patient
group
fig
tabl
rsv
respiratori
syncyti
viru
ci
confid
interv
cc
motif
chemokin
ligand
induc
nitric
oxid
synthas
paramet
show
signific
differ
among
group
bonferroni
correct
p
type
viru
screen
patient
bronchiol
b
paramet
show
signific
differ
group
bonferroni
correct
p
fisher
exact
test
test
appli
consid
data
distribut
mdr
analysi
show
evid
interact
genet
viral
data
acut
sever
viral
bronchiol
posit
associ
data
show
associ
polymorph
bronchiol
sever
data
patient
patient
without
comorbid
odd
ratio
ci
confid
interv
icu
intens
care
unit
paramet
show
signific
differ
among
group
bonferroni
correct
p
snp
tt
show
signific
differ
group
icu
admiss
patient
group
bonferroni
correct
p
fisher
exact
test
test
appli
consid
data
distribut
statist
model
appli
genet
analysi
consid
snp
genotyp
use
odd
ratio
calcul
present
parenthes
mdr
analysi
show
evid
interact
clinic
genet
data
acut
sever
viral
bronchiol
posit
associ
axi
scale
mdr
analysi
show
evid
interact
genet
variant
enrol
sever
acut
viral
bronchiol
healthi
control
patient
outcom
posit
interact
observ
among
clinic
data
signific
associ
find
snp
allel
presenc
bronchiol
consid
presenc
comorbid
tabl
best
knowledg
first
studi
associ
snp
gene
involv
immun
respons
sever
bronchiol
compar
outcom
patient
admit
hospit
studi
analyz
preval
bronchiol
compar
patient
control
examin
sever
bronchiol
compar
inpati
patient
seen
emerg
room
discharg
ci
confid
interv
icu
intens
care
unit
tolllik
receptor
tolllik
receptor
cc
motif
chemokin
ligand
vdr
vitamin
receptor
paramet
show
signific
differ
among
group
bonferroni
correct
p
paramet
show
signific
differ
among
group
bonferroni
correct
p
fisher
exact
test
test
appli
consid
data
distribut
mdr
analysi
show
evid
interact
genet
clinic
data
acut
sever
viral
bronchiol
posit
previou
associ
ae
alvarez
et
al
gene
odd
ratio
ci
confidenti
interv
tolllik
receptor
tolllik
receptor
tolllik
receptor
cc
motif
chemokin
ligand
vdr
vitamin
receptor
induc
nitric
oxid
synthas
interferon
alpha
jun
jun
protooncogen
transcript
factor
subunit
savb
sever
acut
viral
bronchiol
utr
untransl
region
refer
test
appli
consid
data
distribut
odd
ratio
ci
confidenti
interv
tolllik
receptor
tolllik
receptor
tolllik
receptor
cc
motif
chemokin
ligand
vdr
vitamin
receptor
induc
nitric
oxid
synthas
interferon
alpha
jun
jun
protooncogen
transcript
factor
subunit
savb
sever
acut
viral
bronchiol
utr
untransl
region
refer
test
appli
consid
data
distribut
rsv
present
patient
patient
rsva
rsvb
second
common
viru
rhinoviru
present
patient
viral
codetect
present
patient
codetect
report
patient
bronchiol
et
al
controversi
exist
regard
influenc
presenc
codetect
sever
bronchiol
studi
suggest
codetect
increas
sever
bronchiol
et
al
da
silva
et
al
studi
shown
patient
viral
codetect
present
seriou
diseas
patient
infect
singl
viru
ricart
et
al
brand
et
al
studi
codetect
associ
patient
age
frequenc
nurseri
attend
associ
bronchiol
sever
influenc
codetect
bronchiol
sever
object
studi
make
extens
discuss
topic
interact
rsv
fusion
protein
lead
product
proinflammatori
cytokin
interleukin
tumor
necrosi
factor
surfact
protein
factor
direct
antivir
properti
other
stimul
activ
natur
killer
cell
granulocyt
monocyt
macrophag
thu
initi
adapt
immun
respons
farrag
almajhdi
arruvito
et
al
lambert
et
al
choi
et
al
tlr
defici
may
lead
absenc
polar
signal
chang
cell
respons
protect
cytotox
cell
immun
toward
dysregul
polar
caus
bronchiol
suscept
infant
farrag
almajhdi
arruvito
et
al
recent
studi
demonstr
rsv
fusion
protein
capabl
induc
format
neutrophil
extracellular
trap
net
immobil
kill
pathogen
activ
excess
product
net
contribut
patholog
respiratori
viral
infect
funchal
et
al
previou
studi
found
sever
rsv
bronchiol
associ
snp
tal
et
al
puthothu
et
al
moreov
peripher
blood
mononuclear
cell
children
express
exon
variant
shown
blunt
respons
rsv
ricart
et
al
howev
studi
found
associ
snp
bronchiol
et
al
goutaki
et
al
present
studi
found
death
bronchiol
associ
snp
associ
detect
bronchiol
sever
snp
snp
recent
associ
increas
risk
asthma
develop
children
histori
bronchiol
lee
et
al
follow
patient
verifi
associ
bronchiol
sever
viru
type
genet
polymorph
asthma
develop
environment
factor
also
shown
interact
genotyp
modul
rsv
infect
sever
caballero
et
al
express
surfac
immun
cell
tissu
heterodim
complex
either
use
knockout
mice
signal
leukocyt
shown
activ
innat
immun
rsv
promot
tumor
necrosi
factor
alpha
chemokin
cc
motif
ligand
ccl
import
control
viral
replic
promot
neutrophil
migrat
dendrit
cell
activ
vivo
murawski
et
al
addit
signal
report
influenc
express
follow
certain
stimuli
suggest
role
respons
rsv
fan
et
al
one
studi
found
associ
polymorph
bronchiol
sever
nuolivirta
et
al
found
death
bronchiol
associ
snp
patient
without
comorbid
previous
associ
differ
diseas
bronchial
asthma
lazaru
et
al
addit
rsv
shown
inhibit
product
human
plasmacytoid
dendrit
cell
signal
schlender
et
al
respons
upregul
characterist
seen
sever
rsvassoci
diseas
thu
involv
genet
bronchiol
seem
reason
associ
snp
rsv
infect
document
earlier
studi
mailaparambil
et
al
found
snp
associ
requir
icu
admiss
snp
also
associ
need
mechan
ventil
cours
rsv
infect
enhanc
chemokin
activ
modul
cell
recruit
infiltr
inflamm
site
chemokin
produc
tlymphocyt
macrophag
platelet
epitheli
cell
attract
monocyt
eosinophil
basophil
memori
tlymphocyt
area
infect
highli
express
respiratori
epitheli
cell
line
nasal
secret
bronchoalveolar
lavag
rsvinfect
subject
moreov
evid
support
associ
activ
rsv
infect
hattori
et
al
previou
studi
report
associ
snp
promot
region
snp
intron
rsv
bronchiol
caballero
et
al
howev
anoth
studi
found
associ
rsv
bronchiol
snp
test
separ
observ
significantli
common
combin
snp
genotyp
patient
control
amanatid
et
al
found
associ
snp
ct
bronchiol
caus
rsv
rsv
subtyp
specif
also
found
snp
associ
need
mechan
ventil
bronchiol
patient
respiratori
tract
nitrit
oxid
produc
wide
varieti
cell
type
gener
via
oxid
larginin
catalyz
enzym
synthas
no
no
exist
three
distinct
isoform
neuron
no
nno
induc
no
ino
endotheli
no
eno
deriv
ino
seem
proinflammatori
mediat
immunomodulatori
effect
respiratori
tract
alon
express
ino
report
alveolar
type
ii
epitheli
cell
lung
fibroblast
airway
vascular
smooth
muscl
cell
airway
respiratori
epitheli
cell
mast
cell
endotheli
cell
neutrophil
chondrocyt
stimuli
caus
transcript
activ
ino
cell
vari
wide
includ
endogen
mediat
chemokin
cytokin
well
exogen
factor
bacteri
toxin
viru
infect
allergen
environment
pollut
hypoxia
tumor
etc
high
level
releas
ino
effect
immun
effector
molecul
halt
viral
replic
elimin
variou
pathogen
mechan
may
involv
least
part
inhibit
dna
synthesi
inactiv
ribonucleotid
reductas
direct
deamin
dna
final
appear
signal
reactiv
cystein
group
particularli
locat
consensu
motif
snitrosyl
primari
sequenc
tertiari
structur
protein
one
gener
mechan
antimicrobi
defens
involv
snitrosyl
cystein
proteas
critic
virul
replic
mani
virus
bacteria
parasit
ricciardolo
et
al
previou
studi
demonstr
associ
snp
rsv
bronchiol
janssen
et
al
found
associ
snp
bronchiol
caus
rhinoviru
vitamin
modul
white
blood
cell
prolifer
matur
cytokin
express
vdr
lymphocyt
macrophag
vdr
signal
also
contribut
express
antimicrobi
peptid
import
innat
defens
virus
bacteria
liu
et
al
lower
vitamin
level
postul
risk
factor
respiratori
ill
base
wellestablish
season
respiratori
infect
occur
winter
uvb
product
vitamin
low
subsequ
bronchiol
research
develop
countri
investig
subclin
vitamin
defici
support
hypothesi
roth
et
al
addit
prospect
newborn
cohort
studi
identifi
low
cord
blood
vitamin
level
independ
predictor
rsv
infect
first
year
life
belderbo
et
al
genet
alter
vdr
potenti
affect
vitamin
signal
impair
gene
transcript
mrna
stabil
translat
protein
activ
protein
stabil
common
vdr
snp
previous
associ
moder
lower
vdr
transcript
activ
recent
metaanalysi
conclud
presenc
snp
vdr
allel
significantli
increas
risk
rsv
bronchiol
mcnalli
et
al
similarli
found
snp
vdr
associ
death
bronchiol
current
studi
airway
epitheli
cell
vitamin
control
express
signal
transduc
activ
transcript
stat
recent
studi
demonstr
predisposit
snp
vdr
sever
rsv
bronchiol
may
involv
impair
abil
vitamin
restrain
antivir
signal
airway
epithelia
vitamin
fail
regul
phosphoryl
downstream
gene
express
cell
express
vdr
variant
strong
activ
pathway
rsvinfect
cell
may
therefor
contribut
rsv
immunopathogenesi
stoppelenburg
et
al
two
studi
found
anoth
vdr
snp
associ
increas
likelihood
bronchiol
carrier
allel
like
develop
diseas
kresfeld
et
al
janssen
et
al
also
regard
gene
immun
system
recent
studi
report
snp
show
signific
associ
sever
acut
viral
bronchiol
pinto
et
al
develop
rsv
vaccin
high
prioriti
public
health
attempt
date
frustrat
resolv
mechan
rsv
induc
pathogenesi
essenti
develop
new
effect
vaccin
farrag
almajhdi
arruvito
et
al
jorquera
et
al
higgin
et
al
final
regard
hwe
must
rememb
hwe
assum
ideal
popul
without
interfer
evolutionari
factor
howev
gene
involv
immun
inflamm
infect
control
hwe
imbal
may
appear
secondarili
associ
select
mechan
favor
particular
allel
bring
effect
respons
disequilibrium
invalid
associ
studi
sinc
group
part
popul
number
limit
studi
includ
superfici
character
popul
healthi
control
ii
miscegen
popul
extens
present
group
evalu
ethnic
assess
perform
selfreport
manner
studi
ancestri
control
patient
iii
sampl
size
reduct
due
nonidentif
snp
genotyp
patient
difficulti
obtain
clinic
laboratori
marker
patient
includ
studi
iv
number
evalu
carri
time
may
lead
confound
v
limit
size
sampl
includ
studi
power
sampl
obtain
analyz
perform
need
correct
multipl
test
high
denomin
vi
use
candid
gene
studi
model
rather
genomewid
associ
studi
due
technic
limit
high
cost
involv
laboratori
analysi
find
provid
evid
genet
variat
select
immun
gene
may
influenc
outcom
sever
bronchiol
replic
dataset
need
determin
polymorph
immun
respons
gene
could
use
futur
work
help
predict
highrisk
infant
might
benefit
prevent
measur
knowledg
snp
associ
sever
bronchiol
also
contribut
understand
diseas
pathogenesi
innat
immun
respons
infect
use
guid
effort
develop
effect
treatment
potenti
fatal
infect
studi
approv
nation
research
ethic
commiss
number
legal
repres
patient
particip
control
group
receiv
explan
research
gave
written
inform
consent
author
declar
conflict
interest
author
report
financi
relationship
relev
subject
articl
fund
sourc
aea
paulo
research
foundat
fapesp
grant
roberto
rocha
brito
foundat
vera
cruz
hospit
grant
falm
fapesp
grant
jdr
fapesp
grant
aea
conceiv
design
studi
select
patient
perform
clinic
evalu
patient
includ
studi
acquir
data
analyz
statist
data
draft
revis
approv
submit
final
manuscript
falm
conceiv
design
studi
perform
polymorph
screen
analyz
statist
data
draft
revis
approv
final
manuscript
csb
conceiv
design
studi
perform
polymorph
screen
revis
approv
final
manuscript
cwa
jcsb
conceiv
design
studi
perform
viral
identif
revis
approv
final
manuscript
eceb
att
conceiv
design
studi
revis
approv
final
manuscript
mtnr
mbm
ccba
pg
ec
mlfm
mcr
jvp
select
patient
acquir
data
revis
approv
final
manuscript
jdr
conceiv
design
studi
analyz
statist
data
draft
revis
approv
final
manuscript
